Current status and recent advances of lymph node micrometastase in patients with gastric cancer

Abstract

Abstract:There is still a certain recurrence rate after extensive lymphadenectomy even to patients with nodenegative gastric cancer. It promotes the researchers to use a more sensitive and effective way to track tumor cells which are missed, especially lymph node micrometastases. With the development of detection technology, the diagnostic rate of micrometastasis is significantly increased. There are so many controversies about the impact of lymph node micrometastases that no consensus on the clinical treatment can be reached. In recent years, with the rise of endoscopic therapy, how to balance the relationship between the quality of life and the safety makes the research of micrometastases more urgent.

Key words:Stomach neoplasms,Lymph nodes,Neoplasm metastasis

Zhou Yang, Fu Weihua. Current status and recent advances of lymph node micrometastase in patients with gastric cancer[J]. Journal of International Oncology, 2016, 43(10): 791-794.

References

［1］ Jeuck TL, Wittekind C. Gastric carcinoma: stage migration by immunohistochemically detected lymph node micrometastases［J］. Gastric Cancer, 2015, 18(1): 100108. DOI: 10.1007/s1012001403524. ［2］ Zhou Y, Yu F, Wu L, et al. Survival after gastrectomy in nodenegative gastric cancer: a review and metaanalysis of prognostic factors［J］. Med Sci Monit, 2015, 21: 19111919. DOI: 10.12659/MSM.893856. ［3］ Lee CM, Park SS, Kim JH. Current status and scope of lymph node micrometastasis in gastric cancer［J］. J Gastric Cancer, 2015, 15(1): 19. DOI: 10.5230/jgc.2015.15.1.1. ［4］陈嘉健. 乳腺癌前哨淋巴结微转移的检测与临床意义［J］. 国际肿瘤学杂志, 2008, 35(7): 502505. DOI: 10.3760/cma.j.issn.1673422X.2008.07.008. ［5］ Yoon H, Lee DH. New approaches to gastric cancer staging: beyond endoscopic ultrasound, computed tomography and positron emission tomography［J］. World J Gastroenterol, 2014, 20(38): 13783. DOI: 10.3748/wjg.v20.i38.13783. ［6］ Fukagawa T, Sasako M, Ito S, et al. The prognostic significance of isolated tumor cells in the lymph nodes of gastric cancer patients［J］. Gastric Cancer, 2010, 13(3): 191196. DOI: 10.1007/s1012001005561. ［7］ Hata M, Machi J, Mamou J, et al. Entirevolume serial histological examination for detection of micrometastases in lymph nodes of colorectal cancers［J］. Pathol Oncol Res, 2011, 17(4): 835841. DOI: 10.1007/s122530119390y. ［8］ Wang J, Yu JC, Kang WM, et al. The predictive effect of cadherin17 on lymph node micrometastasis in pN0 gastric cancer［J］. Ann Surg Oncol, 2012, 19(5): 15291534. DOI: 10.1245/s1043401121153. ［9］ Torlakovic EE, Nielsen S, Vyberg MA. Getting controls under control: the time is now for immunohistochemistry［J］. J Clin Pathol, 2015, 68(11): 879882. DOI: 10.1136/jclinpath2014202705. ［10］ Muto Y, Matubara H, Tanizawa T, et al. Rapid diagnosis of micrometastasis of gastric cancer using reverse transcription loopmediated isothermal amplification［J］. Oncol Rep, 2011, 26(4): 789794. DOI: 10.3892/or.2011.1389. ［11］ Jagric T, Ivanecz A, Horvat M, et al. Evaluation of a focused sentinel lymph node protocol in nodenegative gastric cancer patients［J］. Hepatogastroenterology, 2013, 60(125): 12311236. DOI: 10.5754/hge121167. ［12］ Wollants E, Van Ranst M. Detection of false positives with a commonly used Norovirus RTPCR primer set［J］. J Clin Virol, 2013, 56(1): 8485. DOI: 10.1016/j.jcv.2012.09.007. ［13］ Spychaa A, Murawa D, Korski K. The clinical importance of micrometastases within the lymphatic system in patients after total gastrectomy［J］. Rep Pract Oncol Radiother, 2011, 16(6): 232236. DOI: 10.1016/j.rpor.2011.08.002. ［14］ Kim JH, Park SS, Park SH. Clinical significance of immunohistochemicallyidentified lymphatic and/or blood vessel tumor invasion in gastric cancer［J］. J Surg Res, 2010, 162(2): 177183. DOI: 10.1016/j.jss.2009.07.015. ［15］ Sonoda H, Tani T. Clinical significance of molecular diagnosis for gastric cancer lymph node micrometastasis［J］. World J Gastroenterol, 2014, 20(38): 1372813733. DOI: 10.3748/wjg.v20.i38.13728. ［16］ Lee CM, Cho JM, Jang YJ, et al. Should lymph node micrometastasis be considered in node staging for gastric cancer?［J］. Ann Surg Oncol, 2015, 22(3): 765771. DOI: 10.1245/s104340144073z. ［17］ Tavares A, MonteiroSoares M, Viveiros FA, et al. Occult tumor cells in lymph nodes of patients with gastric cancer: a systematic review on their prevalence and predictive role［J］. Oncology, 2015, 89(5): 245254. DOI: 10.1159/000433543. ［18］ Lee T, Tanaka H, Ohira M, et al. Clinical impact of the extent of lymph node micrometastasis in undifferentiatedtype early gastric cancer［J］. Oncology, 2014, 86(4): 244252. DOI: 10.1159/000358803. ［19］ Li Y, Du P, Zhou Y, et al. Lymph node micrometastases is a poor prognostic factor for patients in pN0 gastric cancer: a metaanalysis of observational studies［J］. J Surg Res, 2014, 191(2): 413422. DOI: 10.1016/j.jss.2014.05.088. ［20］ Cao L, Hu X, Zhang Y, et al. Adverse prognosis of clusteredcell versus singlecell micrometastases in pN0 early gastric cancer［J］. J Surg Oncol, 2011, 103(1): 5356. DOI: 10.1002/jso.21755. ［21］ Zeng YJ, Zhang CD, Dai DQ. Impact of lymph node micrometastasis on gastric carcinoma prognosis: a metaanalysis［J］. World J Gastroenterol, 2015, 21(5): 16281635. DOI: 10.3748/wjg.v21.i5.1628. ［22］ Degiuli M, Sasako M, Ponti A, et al. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer［J］. Br J Surg, 2014, 101(2): 2331. DOI: 10.1002/bjs.9345. ［23］ Chen XZ, Hu JK, Zhou ZG, et al. Metaanalysis of effectiveness and safety of D2 plus paraaortic lymphadenectomy for resectable gastric cancer［J］. J Am Coll Surg, 2010, 210(1): 100105. DOI: 10.1016/j.jamcollsurg.2009.09.033. ［24］ Kume K. Endoscopic therapy for early gastric cancer: standard techniques and recent advances in ESD［J］. World J Gastroenterol, 2014, 20(21): 64256432. DOI: 10.3748/wjg.v20.i21.6425. ［25］ Gotoda T, Iwasaki M, Kusano C, et al. Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria［J］. Br J Surg, 2010, 97(6): 868871. DOI: 10.1002/bjs.7033. ［26］ Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition［J］. Gastric Cancer, 2011, 14(2): 101112. DOI: 10.1007/s1012001100415. ［27］ Gurzu S, Jung I, Kadar Z. Aberrant metastatic behavior and particular features of early gastric cancer［J］. APMIS, 2015, 123(12): 9991006. DOI: 10.1111/apm.12469.

[1]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[2]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[3]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[4]	Xie Shuping, Sun Yahong, Wang Chao.Prediction of efficacy of early-stage tumor markers combined with NLR and PLR for immunotherapy in gastric cancer[J]. Journal of International Oncology, 2024, 51(3): 157-165.
[5]	Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.Progress of radiotherapy in oligometastatic non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 170-174.
[6]	Liu Yulan, Jing Haiyan, Sun Jing, Song Wei, Sha Dan.Advances in predicting efficacy and prognostic markers of immunotherapy for gastric cancer[J]. Journal of International Oncology, 2024, 51(3): 175-180.
[7]	Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.Research progress on the histopathological growth patterns of colorectal liver metastasis[J]. Journal of International Oncology, 2024, 51(2): 114-118.
[8]	Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying.Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer[J]. Journal of International Oncology, 2023, 50(8): 475-483.
[9]	Shao Huifang, Wang Xuehong, Lu Yongfu.Mechanism of action and clinical significance of CST1 in the progression of gastric cancer[J]. Journal of International Oncology, 2023, 50(8): 489-492.
[10]	Zhu Siyu, Wang Xuehong, Li Wenqian, Liu Shu.Level of serum FABP1 and its relationship withHelicobacter pyloriinfection in patients with gastric cancer[J]. Journal of International Oncology, 2023, 50(6): 336-341.
[11]	Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway[J]. Journal of International Oncology, 2023, 50(4): 202-207.
[12]	Yang Lirong, Wang Yufeng.Construction of machine learning models for predicting the risk of postoperative distant metastasis recurrence in serous ovarian cancer[J]. Journal of International Oncology, 2023, 50(4): 220-226.
[13]	Ji Wei, Guan Quanlin, Chen Yarui, Jiao Fuzhi, Luo Qianwen.Correlation between blood lipid level and gastric cancer[J]. Journal of International Oncology, 2023, 50(3): 183-185.
[14]	Fan Shanlin, Wang Pinxiu, Kong Fei, Zhou Yujie, Yuan Wenzhen.Progress in the study of predictors of tumor regression grade after neoadjuvant chemotherapy for gastric cancer[J]. Journal of International Oncology, 2023, 50(2): 112-116.
[15]	Ma Peihan, Zhang Lingming, Lu Ning, Zhang Mingxin.Effect of anesthesia on the recurrence and metastasis of hepatocellular carcinoma[J]. Journal of International Oncology, 2023, 50(2): 117-121.